

1,402,067 filings since 2004 · latest accepted Nov 4, 2026, 8:16 AM ET
Priority items usually mark a change in credit, accounting integrity, control or listing status: 1.02 Agreement terminated, 1.03 Bankruptcy, 1.05 Cybersecurity incident, 2.04 Debt acceleration, 2.05 Restructuring costs, 2.06 Impairment, 3.01 Delisting notice, 4.01 Auditor change, 4.02 Non-reliance (restatement), 5.01 Change in control.
| Filed | Company | Items | Filing |
|---|---|---|---|
Oct 22, 2026 accepted 11:31 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 5.02Officer / director change8.01Other events | DocumentSEC ↗ |
Jun 1, 2026 accepted 11:00 AM ET | ELOXEloxx Pharmaceuticals, Inc. | Unregistered equity sale |
Source: SEC EDGAR. Same-day filings appear within minutes and are re-checked against SEC's nightly index. Tickers are current listings, so a company's older filings show its ticker today.
| DocumentSEC ↗ |
Aug 12, 2025 accepted 9:22 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Oct 17, 2024 accepted 8:01 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Mar 29, 2024 accepted 8:11 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Dec 28, 2023 accepted 9:11 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Sep 15, 2023 accepted 9:15 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Aug 29, 2023 accepted 8:32 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Jul 5, 2022 accepted 12:28 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 5.02Officer / director change7.01Reg FD disclosure | DocumentSEC ↗ |